The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review
Open accessAbstract
Drug interactions are a leading cause of morbidity and mortality. Methadone and buprenorphine are frequently prescribed for the treatment of opioid addiction. Patients needing treatment with these medications often have co‐occurring medical and mental illnesses that require medication treatment. The abuse of illicit substances is also common in opioid‐addicted individuals. These clinical realities place patients being treated with methadone and buprenorphine at risk for potentially toxic drug interactions. A substantial literature has accumulated on drug interactions between either methadone or buprenorphine with other medications when ingested concomitantly by humans. This review summarizes current literature in this area. (Am J Addict 2009;19:4–16)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lauer, G. M., & Walker, B. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107053450107 · Cited by 2,973
Clinical pharmacology of buprenorphine: Ceiling effects at high doses
Walsh, S. L., Preston, K. L., Stitzer, M. L., Cone, E. J., & Bigelow, G. E. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.71 · Cited by 773
Psychiatric and Substance Use Comorbidity Among Treatment-Seeking Opioid Abusers
Brooner, R. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130077015 · Cited by 746
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1053/jhep.2002.36810 · Cited by 727
Mechanisms of fatal opioid overdose
White, J. M., & Irvine, R. J. (1999) · Addiction · doi:10.1046/j.1360-0443.1999.9479612.x · Cited by 633
Clinically relevant drug interactions with antiepileptic drugs
Perucca, E. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2005.02529.x · Cited by 602
QTc Interval Screening in Methadone Treatment
Krantz, M. J., Martin, J., Stimmel, B., Mehta, D., & Haigney, M. C. P. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00103 · Cited by 337
The Principles of Addiction Medicine
(2007) · Addiction and the Medical Complications of Drug Abuse · doi:10.1201/9781420054446-5 · Cited by 332
Sulkowski, M. S., Mast, E. E., Seeff, L. B., & Thomas, D. L. (2000) · Clinical Infectious Diseases · doi:10.1086/313842 · Cited by 251
Dose‐Related Effects of Methadone on QT Prolongation in a Series of Patients with Torsade de Pointes
Krantz, M. J., Kutinsky, I. B., Robertson, A. D., & Mehler, P. S. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.6.802.32186 · Cited by 232
Research works printed but not linked: 21
- 10.1111/j.1556-4029.2007.00565.x · doi:10.1111/j.1556-4029.2007.00565.x
- 10.1016/j.drugalcdep.2008.12.009 · doi:10.1016/j.drugalcdep.2008.12.009
- 10.1097/ALN.0b013e3181986a9a · doi:10.1097/aln.0b013e3181986a9a
- 10.1097/00042560-200007010-00008 · DOI
- 10.1177/0091270007308034 · doi:10.1177/0091270007308034
- Schwartz EL, 1992, Pharmacokinetic interactions of zidovudine and methadone in intravenous drug‐using patients with HIV infection, J Acquir Immune Defic Syndr, 5, 619
- FriedlandG RaineyP JatlowP et al.Pharmacokinetics of didanosine from encapsulated enteric coated bead formulation vs chewable tablet formulation in patients on chronic methadone therapy.Paper Presented at: 14th International AIDS Conference;July 2002; Barcelona Spain .
- 10.1007/978-1-4757-9209-6_25 · doi:10.1007/978-1-4757-9209-6_25
- 10.1097/01.aids.0000216384.22432.9a · doi:10.1097/01.aids.0000216384.22432.9a
- 10.1089/088922202753519115 · doi:10.1089/088922202753519115
- McCance‐KatzEF.Drug Interactions between Opioids and Infectious Disease Therapeutics: Why Should We CareAmerican Society of Addiction Medicine Annual Meeting NIDA Symposium. New Orleans LA April 2009.
- 2005, Physician's Desk Reference, 2480
- 2005, Physician's Desk Reference
- 2009, Physicians' Desk Reference, 411
- 10.1520/JFS14088J · doi:10.1520/jfs14088j
- 10.2174/1389200033489523 · doi:10.2174/1389200033489523
- 10.1016/j.amjopharm.2005.03.002 · doi:10.1016/j.amjopharm.2005.03.002
- 10.1007/BF03189409 · doi:10.1007/bf03189409
- 10.1186/1742-4690-2-S1-P142 · doi:10.1186/1742-4690-2-s1-p142
- 10.1016/0024-3205(94)00501-I · doi:10.1016/0024-3205(94)00501-i
- 10.1300/J251v03n04_04 · doi:10.1300/j251v03n04_04
Cited by
Maintenance Medication for Opiate Addiction: The Foundation of Recovery
Bart, G. (2012) · Journal of Addictive Diseases · doi:10.1080/10550887.2012.694598 · Cited by 461
Els, C., Jackson, T. D., Kunyk, D., Lappi, V. G., Sonnenberg, B., Hagtvedt, R., Sharma, S., Kolahdooz, F., & Straube, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012509.pub2 · Cited by 284
Greenwald, M. K., Comer, S. D., & Fiellin, D. A. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.07.035 · Cited by 174
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1409722 · Cited by 141
Sartori, S., Crescioli, G., Brilli, V., Traversoni, S., Lanzi, C., Vannacci, A., Mannaioni, G., & Lombardi, N. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-02976-0 · Cited by 11
Metadata
- Authors
- McCance‐Katz, E. F., Sullivan, L. E., & Nallani, S.
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2009-12-16
- Volume
- 19
- Issue
- 1
- Pages
- 4-16
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- OpenAlex
- W1877120840
- Cited by
- 318
- References
- 67
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review. https://app.cochat.ai/papers/10.1111/j.1521-0391.2009.00005.x
- The paper
- McCance‐Katz, E. F., Sullivan, L. E., & Nallani, S. (2010). Drug Interactions of Clinical Importance among the Opioids, Methadone and Buprenorphine, and Other Frequently Prescribed Medications: A Review. The American Journal on Addictions. https://doi.org/10.1111/j.1521-0391.2009.00005.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.